Jason Rhodes

Jason has served as the chairman of our board of directors since October 2017 and served as our founding chief executive officer from October 2016 to October 2017. Jason has been a partner at Atlas Venture since 2014 and serves as the chairman of the board of directors of Dyne Therapeutics. He previously served as a member of the boards of directors of Replimune Group, Gemini Therapeutics, and Bicycle Therapeutics. Jason also serves on the boards of several private companies, including Rectify Pharmaceuticals, Be Biopharma, K36 Therapeutics, and Accent Therapeutics, where he is also the chair. He previously served on the board of directors of Third Harmonic Bio. Jason earned a BA from Yale University and an MBA from the Wharton School of the University of Pennsylvania.